Template:PDB Gallery/25

• 1ab2: THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABL
  1ab2: THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABL
• 1abo: CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE
  1abo: CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE
• 1abq: CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAIN
  1abq: CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAIN
• 1awo: THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUCTURES
  1awo: THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUCTURES
• 1bbz: CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMPLICATIONS FOR SH3-LIGAND INTERACTIONS
  1bbz: CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMPLICATIONS FOR SH3-LIGAND INTERACTIONS
• 1fpu: CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
  1fpu: CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR
• 1iep: CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
  1iep: CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.
• 1ju5: Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy
  1ju5: Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy
• 1m52: Crystal Structure of the c-Abl Kinase domain in complex with PD173955
  1m52: Crystal Structure of the c-Abl Kinase domain in complex with PD173955
• 1opj: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
  1opj: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
• 1opk: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
  1opk: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
• 1opl: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
  1opl: Structural basis for the auto-inhibition of c-Abl tyrosine kinase
• 1zzp: Solution structure of the F-actin binding domain of Bcr-Abl/c-Abl
  1zzp: Solution structure of the F-actin binding domain of Bcr-Abl/c-Abl
• 2abl: SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE
  2abl: SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE
• 2e2b: Crystal structure of the c-Abl kinase domain in complex with INNO-406
  2e2b: Crystal structure of the c-Abl kinase domain in complex with INNO-406
• 2f4j: Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680
  2f4j: Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680
• 2fo0: Organization of the SH3-SH2 Unit in Active and Inactive Forms of the c-Abl Tyrosine Kinase
  2fo0: Organization of the SH3-SH2 Unit in Active and Inactive Forms of the c-Abl Tyrosine Kinase
• 2g1t: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
  2g1t: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
• 2g2f: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
  2g2f: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
• 2g2h: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
  2g2h: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
• 2g2i: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
  2g2i: A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain
• 2gqg: X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain
  2gqg: X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain
• 2hiw: Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor
  2hiw: Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor
• 2hyy: Human Abl kinase domain in complex with imatinib (STI571, Glivec)
  2hyy: Human Abl kinase domain in complex with imatinib (STI571, Glivec)
• 2hz0: Abl kinase domain in complex with NVP-AEG082
  2hz0: Abl kinase domain in complex with NVP-AEG082
• 2hz4: Abl kinase domain unligated and in complex with tetrahydrostaurosporine
  2hz4: Abl kinase domain unligated and in complex with tetrahydrostaurosporine
• 2hzi: Abl kinase domain in complex with PD180970
  2hzi: Abl kinase domain in complex with PD180970
• 2hzn: Abl kinase domain in complex with NVP-AFG210
  2hzn: Abl kinase domain in complex with NVP-AFG210
• 2o88: Crystal structure of the N114A mutant of ABL-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions
  2o88: Crystal structure of the N114A mutant of ABL-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions